Jeisys Medical Inc.
KRX
₩12,870.00
-0.39%
Delayed · cached 15 min
Fair value analysis
287410
Jeisys Medical Inc.
₩12,900.00
Close used for this calculation
₩4,528.54Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
34/100
Quality radar
Consensus fair value
₩4,528.54
Above FV▼ -64.9% against the close used
Model range ₩1,691.85 – ₩5,673.60
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩1,691.85Fair value₩4,528.54Bull₩5,673.60
FairClose
52-week traded range
52W low ₩7,490.0052W high ₩12,950.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Jeisys Medical Inc. closed at ₩12,900.00, 184.9% above the consensus fair value of ₩4,528.54 drawn from 7 valuation models.
Financial DNA score 34/100 — Weak. P/E of 45.5x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩1,691.85
-86.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩3,039.92
-76.4%
√(22.5 × EPS × BVPS)
EPS=283.68, BVPS=1447.81 · outside Graham range (P/E 45.5, P/B 8.9) — asset-light, treat as a rough floor
P/E Fair Value
₩5,673.60
-56.0%
EPS × 20x (sector P/E)
EPS=283.68, Sector P/E=20x
EV/EBITDA
₩4,729.84
-63.3%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=42.88B
Book Value (P/B)
₩3,433.38
-73.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1447.81, ROE=19.6%, g=3%, r=10%
Reverse DCF
₩12,900.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 18.2% | Historical: 0%
Margin of Safety
₩2,601.34
-79.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3468.46, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.